Skip navigation

Chemical Brimonidine Tartrate

Name Brimonidine Tartrate
CAS Type 1 Name 6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
Equivalent Terms 190342, AGN | 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate | 5-bromo-6-(imidazolidinylideneamino)quinoxaline | 5-bromo-6-(imidazolin-2-ylamino)quinoxaline | AGN190342 | AGN 190342 | AGN-190342 | Alphagan | Alphagan P | Brimonidine | Brimonidine Purite | Brimonidine Tartrate (1:1) | Brimonidine Tartrate (1:1), (S-(R*,R*))-Isomer | Brimonidine Tartrate, (R-(R*,R*))-Isomer | Bromoxidine | Mirvaso | Purite, Brimonidine | Ratio Brimonidine | Ratio-Brimonidine | Sanrosa | Tartrate, Brimonidine | UK14304 | UK 14304 | UK 14,304 | UK-14304 | UK 14,30418 | UK 14,304 18 | UK 14,304-18 | UK-14,304-18 | UK14,30418 | UK 14308 | UK 14,308 | UK-14,308 | UK14,308
Definition A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
Top Interacting
Genes
MeSH® ID D000068438
External Links

Top ↑ Ancestors

ChemicalsHeterocyclic Compounds Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, Fused-Ring Has associated genes Has associated diseases Has associated exposure references Heterocyclic Compounds, 2-Ring Has associated genes Has associated diseases Has associated exposure references Quinoxalines Has associated genes Has associated diseases Has associated exposure references Brimonidine Tartrate Has associated genes Has associated diseases

Top ↑ Descendants

Brimonidine Tartrate Has associated genes Has associated diseases
  Brimonidine Tartrate, Timolol Maleate Drug Combination